Pain relief in breast surgery
Phase 4
- Conditions
- Health Condition 1: C500- Malignant neoplasm of nipple and areolaHealth Condition 2: C508- Malignant neoplasm of overlappingsites of breastHealth Condition 3: C502- Malignant neoplasm of upper-innerquadrant of breast
- Registration Number
- CTRI/2022/11/047142
- Lead Sponsor
- ESIPostgraduate Institute of Medical Sciences and Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients undergoing elective mastectomy surgery
Exclusion Criteria
•Patient refusal
•Contraindications to regional anaesthesia
•Known allergy to local anaesthetics
•Bleeding diathesis
•Use of any anti-coagulants
•Patient on chronic analgesics
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total postoperative analgesic consumptionTimepoint: 24hrs after surgery
- Secondary Outcome Measures
Name Time Method Postoperative pain assessment: Numeric pain Rating score (NRS) at rest and movement. <br/ ><br> <br/ ><br> Total requirement of rescue analgesia (Fentanyl). <br/ ><br> <br/ ><br>Complications, if any, (will be managed subsequently).Timepoint: 30min, 2hrs, 4hrs, 6hrs, 8hrs, 24hrs after surgery